Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2)in human monocytes: Possible involvement of oxygen free radicals

Biochemical Journal

Volumn 357, Issue 1, 2001, Pages 233-240

  Wang, G ^a   Karmin, O ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherosclerosis; Chemotaxis; Oxidative stress; Superoxide

Indexed keywords

BINDING ENERGY; BIOASSAY; CELLS; ENZYME KINETICS; FREE RADICALS; IMMUNOLOGY; PROTEINS; RNA;

LESION SITE;

BIOCHEMISTRY;

FREE RADICAL; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN RADICAL; SUPEROXIDE;

AMINO ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CELL INTERACTION; CELL PROLIFERATION; CHEMOTAXIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 0035396489     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3570233     Document Type: Article

References (51)

1. Hyperhomocysteinemia: An independent risk factor for vascular disease
2. Homocysteine and vascular disease
3. Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease
4. Homocysteine cardiovascular disease
5. Homocysteine and atherothrombosis
6. Homocystinemia. Vascular injury and arterial thrombosis
7. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells
8. Homocysteine-induced arteriosclerosis The role of endothelial cell injury and platelet response in its genesis
9. Plasma homocysteine levels and mortality in patients with coronary artery disease
10. Effect of homocysteine on the production of nitric oxide in endothelial cells
11. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells
12. Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: A possible, role for protein kinase C
13. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation
14. The pathogenesis of atherosclerosis: A perspective for the 1990s
15. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions
16. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE
17. Monocyte chemoattractant protein-1 in human atheromatous plaques
18. Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1
19. The expression of monocyte chemotactic protein (MOP-1) in human vascular endothelium in vitro and in vivo
20. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma
21. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells
22. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
23. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
24. CCR2: From cloning to the creation of knockout mice
25. Chemokines and atherosclerosis
26. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails
27. -/- mice reveals a role for chemokines in initiation of atherosclerosis
28. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler
29. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor γ
30. LPS down-regulates the expression of chemokine receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation
31. Downregulation by tumor necrosis factor-α of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein. A potential mechanism of monocyte retention in atherosclerotic lesions
32. Rapid quantitation of neutrophil chemotaxis: Use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly
33. 2 formation
34. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
35. Superoxide-dependent cerebrovascular effects of homocysteine
36. Non-traditional cardiovascular disease risk factors in end-stage renal disease: Oxidate stress and hyperhomocysteinemia
37. Relationship between homocysteine and superoxide dismutase in homocyslinuria. Possible relevance to cardiovascular risk. Arterioscler
38. Endothelial cell injury due to copper. Catalyzed hydrogen peroxide generation from homocysteine
39. The oxidant stress of hyperhomocysteinemia
40. Hyperhomocysteinemia and oxidative stress. Time for a reality check
41. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
42. Redox regulation of chemokine receptor expression
43. Total homocysteine in plasma or serum. Methods and clinical applications
44. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
45. Homocysteine and cardiovascular disease
46. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
47. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)
48. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines
49. Regulation of CCR2 chemokine receptor mRNA stability
50. 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells
51. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis